v3.26.1
Segment and Geographic Information - Schedule of Segment Information - Summary of Financial Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenue $ 144,795 $ 143,338 $ 293,437 $ 290,774
Segment adjusted operating loss (6,952) (2,727) (6,335) (263)
Amortization expense 5,600 6,100 11,100 12,200
Transformation costs 440 5,183 1,642 8,229
Restructuring charges 1,422 3,580 2,565 4,011
Impairment of goodwill and intangible assets 149,083 0 149,083 0
Merger and acquisition costs 2,175 688 2,188 2,258
Other miscellaneous expenses 79 (95) 166 (50)
Operating loss (165,790) (18,194) (173,027) (26,895)
Interest income, net 4,387 4,489 9,485 8,787
Other income, net 4,059 1,158 4,138 2,362
Loss from continuing operations before income taxes (157,344) (12,547) (159,404) (15,746)
Completed technology        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Amortization expense 2,076 2,308 3,935 3,808
Other intangible assets        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Amortization expense 3,563 3,803 7,113 8,376
Sample Management Solutions        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenue 81,091 79,816 162,515 160,954
Segment adjusted operating loss 3,115 2,809 8,092 7,580
Restructuring charges 100 1,400 1,300 1,600
Operating loss 3,115 2,809 8,092 7,580
Multiomics        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenue 63,704 63,522 130,922 129,820
Segment adjusted operating loss (10,067) (5,536) (14,427) (7,843)
Restructuring charges 1,300 1,500 1,300 1,600
Operating loss $ (10,067) $ (5,536) $ (14,427) $ (7,843)